Connect your AI

SelectQuote SLQT Senior Segment — Cost of goods sold—pharmacy revenue

Other segment segments

Healthcare Services

$169.81M+5.5%

Life

$0—

Similar metrics at other companies

NAG

NAGEPharmaceuticals segment — Cost of Sales

$0—

CVSPharmacy & Consumer Wellness — Cost of products sold

$25.79B-0.1%

NAG

NAGEPharmaceuticals segment — Selling

$0—

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

EXELReportable Segment — Cost of goods sold

$19.95M+4.1%

INDVReportable Segment — Cost of Sales

$40M-9.1%

Other financials

Income statement

Revenue$430.9M+5.6%

Gross profit$259.6M+5.6%

Operating income$35.9M+62.9%

Net income$40.2M+54.5%

EPS (diluted)$0.11+267%

Balance sheet

Cash & equivalents$35.2M-59.2%

Total debt$404.8M-4.5%

Total equity$384.7M+9.9%

Total assets$1.3B+3.0%

Cash flow

Operating cash flow$56.8M-20.2%

CapEx$947.0K-0.2%

Free cash flow$55.8M-20.4%

Valuation

Market cap$139.42M-65.1%

Enterprise value$509.04M-34.8%

P/E1.5×-6.9×

P/S0.1×-0.2×

Profitability

Gross margin54.2%-7.6pp

Operating margin5.4%—

Net margin5.6%+5.3pp

FCF margin-0.4%-3.3pp

Returns & leverage

Return on equity25%+23.9pp

Debt / equity1.1×-0.2×

Current ratio1.6×-0.3×

Where this comes from

Reported directly by SelectQuote in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: SelectQuote’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about SelectQuote's senior segment — cost of goods sold—pharmacy revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SelectQuote's senior segment — cost of goods sold—pharmacy revenue?: SelectQuote (SLQT) reported senior segment — cost of goods sold—pharmacy revenue of $0 in Q1 2026.
What does senior segment — cost of goods sold—pharmacy revenue mean?: Represents the direct costs incurred to provide pharmacy-related products or services within the segment. This metric is used to assess the profitability and cost efficiency of pharmacy-specific offerings separate from core insurance distribution activities.